D-Index & Metrics Best Publications
Microbiology
Spain
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 78 Citations 30,789 378 World Ranking 356 National Ranking 10
Medicine D-index 85 Citations 34,193 489 World Ranking 7747 National Ranking 98

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Spain Leader Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Virus
  • Disease

Maria Buti focuses on Internal medicine, Gastroenterology, Hepatitis B, Hepatitis B virus and Immunology. The study incorporates disciplines such as Lamivudine and Ribavirin in addition to Internal medicine. Her Gastroenterology research is multidisciplinary, incorporating elements of Surgery and Combination therapy.

Her biological study spans a wide range of topics, including Viral hepatitis, Viral load, Adefovir, Reverse-transcriptase inhibitor and Entecavir. Her Hepatitis B virus study is concerned with the larger field of Virology. The various areas that Maria Buti examines in her Virology study include Antibody and Genotype, Hepatitis E virus.

Her most cited work include:

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (1745 citations)
  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (1320 citations)
  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study (1040 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Internal medicine, Virology, Gastroenterology, Hepatitis B virus and Hepatitis B. Her research integrates issues of Chronic hepatitis, Ribavirin and Immunology in her study of Internal medicine. Her Genotype research extends to Virology, which is thematically connected.

Her work on Liver disease as part of general Gastroenterology study is frequently linked to In patient, therefore connecting diverse disciplines of science. Maria Buti has researched Hepatitis B in several fields, including Entecavir and Viral hepatitis. As a part of the same scientific family, Maria Buti mostly works in the field of Cirrhosis, focusing on Hepatocellular carcinoma and, on occasion, Incidence.

She most often published in these fields:

  • Internal medicine (55.54%)
  • Virology (42.91%)
  • Gastroenterology (38.24%)

What were the highlights of her more recent work (between 2018-2021)?

  • Internal medicine (55.54%)
  • Gastroenterology (38.24%)
  • Hepatitis B virus (28.55%)

In recent papers she was focusing on the following fields of study:

Her primary scientific interests are in Internal medicine, Gastroenterology, Hepatitis B virus, Hepatitis B and HBsAg. Her studies in Internal medicine integrate themes in fields like Entecavir and Chronic hepatitis. Her work deals with themes such as Liver transplantation, Hepatitis C, Adverse effect, Sofosbuvir and Cohort, which intersect with Gastroenterology.

Hepatitis B virus is a subfield of Virology that Maria Buti investigates. Her Hepatitis B research is multidisciplinary, relying on both Liver disease, Disease, Viral replication, Chronic infection and Elevated transaminases. The concepts of her HBsAg study are interwoven with issues in Viral hepatitis, Randomized controlled trial, Cumulative incidence, Confidence interval and Pegylated interferon.

Between 2018 and 2021, her most popular works were:

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
  • Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis (55 citations)
  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

Maria Buti spends much of her time researching Internal medicine, Gastroenterology, Hepatitis B virus, Cirrhosis and Hepatocellular carcinoma. Internal medicine and HBsAg are commonly linked in her work. Her work in Gastroenterology addresses subjects such as Chronic hepatitis, which are connected to disciplines such as Clinical trial and Tenofovir.

Her Hepatitis B virus research includes themes of Tolerability and Hepatitis C virus. Maria Buti focuses mostly in the field of Cirrhosis, narrowing it down to topics relating to Liver transplantation and, in certain cases, Quality of life, Proportional hazards model and Disease. Her Hepatocellular carcinoma study incorporates themes from Entecavir and Liver disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti.
Journal of Hepatology (2017)

2755 Citations

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)

1921 Citations

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal.
The Lancet (2013)

1481 Citations

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane.
The New England Journal of Medicine (2008)

1324 Citations

Hepatitis C virus antibodies among risk groups in Spain.

J.I. Esteban;L. Viladomiu;A. Gonzalez;M. Roget.
The Lancet (1989)

1195 Citations

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.

Tassopoulos Nc;Volpes R;Pastore G;Heathcote J.
Hepatology (1999)

700 Citations

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia☆

Stefan Zeuzem;Maria Buti;Peter Ferenci;Jan Sperl.
Journal of Hepatology (2006)

672 Citations

Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti.
The New England Journal of Medicine (2020)

594 Citations

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

E. Jenny Heathcote;Patrick Marcellin;Maria Buti;Edward Gane.
Gastroenterology (2011)

589 Citations

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)

544 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Maria Buti

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 151

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 146

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 141

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 133

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 123

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 105

Sang Hoon Ahn

Sang Hoon Ahn

Yonsei University

Publications: 100

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 99

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 97

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 96

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 87

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 86

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 84

Markus Cornberg

Markus Cornberg

Hannover Medical School

Publications: 81

Christoph Sarrazin

Christoph Sarrazin

Goethe University Frankfurt

Publications: 81

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 80

Trending Scientists

Marc Goovaerts

Marc Goovaerts

KU Leuven

Ralf Hiptmair

Ralf Hiptmair

ETH Zurich

Jeffrey Rauch

Jeffrey Rauch

University of Michigan–Ann Arbor

Ismail Guvenc

Ismail Guvenc

North Carolina State University

Frank Biocca

Frank Biocca

Syracuse University

A. Ghorbanpour Arani

A. Ghorbanpour Arani

University of Kashan

Frank S. Marzano

Frank S. Marzano

Sapienza University of Rome

Paul J. Krusic

Paul J. Krusic

DuPont (United States)

Joakim Lundeberg

Joakim Lundeberg

Royal Institute of Technology

Michel Vekemans

Michel Vekemans

Necker-Enfants Malades Hospital

Thomas M Glaser

Thomas M Glaser

University of California, Davis

Hans Jacquemyn

Hans Jacquemyn

KU Leuven

Jeffrey R. Gulcher

Jeffrey R. Gulcher

deCODE Genetics (Iceland)

Neal Butchart

Neal Butchart

Met Office

Ian D. Hay

Ian D. Hay

Mayo Clinic

Enzo Pascale

Enzo Pascale

Sapienza University of Rome

Something went wrong. Please try again later.